A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade.

Sahni, Sahil;Wang, Binbin;Wu, Di;Dhruba, Saugato Rahman;Ruppin, Eytan;et.al.
(2024) Nature Communications — Vol. 15, n° 1, p. 8867 (2024)

Files

s41467-024-52555-4.pdf
  • Open Access
  • Adobe PDF
  • 2.66 MB
Download

Details

Authors
Show more
Abstract
Immune checkpoint blockade (ICB) is a promising cancer therapy; however, resistance frequently develops. To explore ICB resistance mechanisms, we develop Immunotherapy Resistance cell-cell Interaction Scanner (IRIS), a machine learning model aimed at identifying cell-type-specific tumor microenvironment ligand-receptor interactions relevant to ICB resistance. Applying IRIS to deconvolved transcriptomics data of the five largest melanoma ICB cohorts, we identify specific downregulated interactions, termed resistance downregulated interactions (RDI), as tumors develop resistance. These RDIs often involve chemokine signaling and offer a stronger predictive signal for ICB response compared to upregulated interactions or the state-of-the-art published transcriptomics biomarkers. Validation across multiple independent melanoma patient cohorts and modalities confirms that RDI activity is associated with CD8 + T cell infiltration and highly manifested in hot/brisk tumors. This study presents a strongly predictive ICB response biomarker, highlighting the key role of downregulating chemotaxis-associated ligand-receptor interactions in inhibiting lymphocyte infiltration in resistant tumors.
Affiliations
  • Wellcome Sanger InstituteExperimental Cancer Genetics

Citations

  • APA
  • Chicago
  • FWB

Sahni, S., Wang, B., Wu, D., Dhruba, S. R., Nagy, M., Patkar, S., Ferreira de Castro Moutinho, I., Day, C.-P., Wang, K., & Ruppin, E. (2024). A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade. Nature Communications, 15(1), 8867. https://doi.org/10.1038/s41467-024-52555-4 (Original work published 2024)